X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6016) 6016
Publication (643) 643
Book Review (53) 53
Book Chapter (43) 43
Newsletter (29) 29
Conference Proceeding (11) 11
Magazine Article (9) 9
Reference (5) 5
Dissertation (4) 4
Newspaper Article (3) 3
Book / eBook (1) 1
Data Set (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4731) 4731
hemolytic-uremic syndrome (3252) 3252
female (2420) 2420
index medicus (2312) 2312
male (2153) 2153
adult (1389) 1389
hemolytic uremic syndrome (1226) 1226
child (1161) 1161
hematology (1086) 1086
urology & nephrology (977) 977
child, preschool (974) 974
thrombotic thrombocytopenic purpura (965) 965
middle aged (959) 959
animals (954) 954
infant (863) 863
adolescent (766) 766
pediatrics (746) 746
immunology (723) 723
hemolytic-uremic syndrome - therapy (639) 639
thrombotic microangiopathy (604) 604
factor-cleaving protease (587) 587
plasma exchange (583) 583
aged (552) 552
hemolytic-uremic syndrome - etiology (548) 548
thrombocytopenic purpura (529) 529
hemolytic-uremic syndrome - blood (519) 519
children (494) 494
hemolytic-uremic syndrome - diagnosis (489) 489
hemolytic-uremic syndrome - complications (484) 484
risk factors (463) 463
purpura, thrombotic thrombocytopenic - therapy (445) 445
transplantation (445) 445
complement (443) 443
escherichia coli (436) 436
microbiology (436) 436
treatment outcome (419) 419
von-willebrand-factor (405) 405
adamts13 protein (400) 400
hemolytic-uremic syndrome - microbiology (393) 393
medicine & public health (392) 392
health aspects (390) 390
retrospective studies (389) 389
disease (387) 387
eculizumab (386) 386
plasma-exchange (381) 381
atypical hemolytic uremic syndrome (376) 376
infectious diseases (374) 374
research (369) 369
shiga toxin (368) 368
mutation (357) 357
care and treatment (349) 349
diagnosis (347) 347
pregnancy (343) 343
nephrology (341) 341
hemolytic-uremic syndrome - pathology (340) 340
mutations (333) 333
escherichia coli infections - microbiology (330) 330
purpura, thrombotic thrombocytopenic - diagnosis (329) 329
mice (327) 327
diarrhea (324) 324
prognosis (319) 319
medicine, general & internal (316) 316
infections (315) 315
infection (312) 312
hemic and lymphatic diseases (303) 303
escherichia-coli (292) 292
hemolytic-uremic syndrome - immunology (292) 292
hemolytic-uremic syndrome - genetics (281) 281
plasma (280) 280
recurrence (277) 277
diagnosis, differential (275) 275
kidney transplantation (272) 272
activation (265) 265
e coli (264) 264
medicine (264) 264
kidney - pathology (263) 263
plasmapheresis (257) 257
antibodies (256) 256
analysis (253) 253
young adult (252) 252
complement factor h - genetics (251) 251
purpura, thrombotic thrombocytopenic - blood (248) 248
anemia (247) 247
endothelial-cells (247) 247
von willebrand factor (246) 246
adamts13 (242) 242
kidneys (236) 236
time factors (236) 236
proteins (235) 235
oncology (234) 234
hemolytic-uremic syndrome - physiopathology (233) 233
pathogenesis (231) 231
therapy (230) 230
alternative pathway (228) 228
article (225) 225
renal dialysis (223) 223
antibodies, monoclonal, humanized - therapeutic use (220) 220
peripheral vascular disease (218) 218
urologic and male genital diseases (218) 218
hemolytic-uremic syndrome - epidemiology (216) 216
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5758) 5758
German (107) 107
Japanese (79) 79
French (60) 60
Spanish (37) 37
Russian (21) 21
Polish (15) 15
Italian (10) 10
Hungarian (7) 7
Korean (7) 7
Chinese (5) 5
Czech (5) 5
Portuguese (4) 4
Dutch (3) 3
Hebrew (3) 3
Norwegian (3) 3
Danish (2) 2
Swedish (2) 2
Turkish (2) 2
Finnish (1) 1
Lithuanian (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2013, Volume 368, Issue 23, pp. 2169 - 2181
Journal Article
Journal Article
Kidney International, ISSN 0085-2538, 05/2014, Volume 85, Issue 5, pp. 1151 - 1160
Antibodies to complement factor H are an uncommon cause of hemolytic uremic syndrome (HUS). Information on clinical features and outcomes in children is... 
acute kidney injury | complement | plasma exchange | intravenous immunoglobulin | hemolytic uremic syndrome | Intravenous immunoglobulin | Plasma exchange | Complement | Hemolytic uremic syndrome | Acute kidney injury | HUS | PHENOTYPE | CLINICAL CHARACTERISTICS | THROMBOTIC THROMBOCYTOPENIC PURPURA | AUTOIMMUNE FORM | DEFICIENCY | COMPLEMENT FACTOR-H | IMPACT | CFHR1 | UROLOGY & NEPHROLOGY | MUTATIONS | Recurrence | Azathioprine - therapeutic use | Age Factors | Autoantibodies - blood | Humans | Immunosuppressive Agents - therapeutic use | Hemolytic-Uremic Syndrome - blood | Child, Preschool | Complement C3b Inactivator Proteins - genetics | Blood Proteins - immunology | Infant | Male | Case-Control Studies | Cyclophosphamide - therapeutic use | Hemolytic-Uremic Syndrome - genetics | Time Factors | Blood Proteins - genetics | Gene Deletion | Female | Hemolytic-Uremic Syndrome - therapy | Hemolytic-Uremic Syndrome - diagnosis | Plasma Exchange - adverse effects | Prednisolone - therapeutic use | Drug Therapy, Combination | Child | Time-to-Treatment | Risk Factors | Rituximab | Treatment Outcome | Combined Modality Therapy | Biomarkers - blood | Hemolytic-Uremic Syndrome - immunology | India | Homozygote | Mycophenolic Acid - analogs & derivatives | Mycophenolic Acid - therapeutic use | Immunosuppressive Agents - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Complement C3b Inactivator Proteins - immunology
Journal Article
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 1, pp. 38 - 47
A mild thrombocytopenia is relatively frequent during pregnancy and has generally no consequences for either the mother or the fetus. Although representing no... 
POSTPARTUM PLASMA-EXCHANGE | PLATELET COUNTS | VON-WILLEBRAND-DISEASE | IMMUNE THROMBOCYTOPENIA | OBSTETRIC PATIENTS | PURPURA | ACUTE FATTY LIVER | HELLP HEMOLYSIS | ELEVATED LIVER-ENZYMES | HEMATOLOGY | FACTOR-CLEAVING PROTEASE | HELLP Syndrome - drug therapy | Recurrence | Humans | Immunosuppressive Agents - therapeutic use | Hemolytic-Uremic Syndrome - blood | Plasma Exchange | Pregnancy Complications, Hematologic - drug therapy | Contraindications | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Young Adult | Purpura, Thrombocytopenic, Idiopathic - therapy | HELLP Syndrome - diagnosis | Thrombocytopenia - drug therapy | Purpura, Thrombotic Thrombocytopenic - drug therapy | Adult | Female | Hemolytic-Uremic Syndrome - therapy | Hemolytic-Uremic Syndrome - diagnosis | Infant, Newborn | Diagnosis, Differential | Antibodies, Monoclonal, Murine-Derived | Thrombocytopenia - etiology | HELLP Syndrome - blood | Purpura, Thrombotic Thrombocytopenic - congenital | Thrombocytopenia - congenital | Rituximab | Anticoagulants - therapeutic use | Combined Modality Therapy | Purpura, Thrombotic Thrombocytopenic - diagnosis | Anticoagulants - adverse effects | Purpura, Thrombotic Thrombocytopenic - prevention & control | Danazol | Algorithms | Purpura, Thrombocytopenic, Idiopathic - diagnosis | Pre-Eclampsia - blood | Immunosuppressive Agents - adverse effects | Thrombocytopenia - diagnosis | Disease Management | Pregnancy - blood | Purpura, Thrombotic Thrombocytopenic - blood | Fetal Monitoring
Journal Article
Blood, ISSN 0006-4971, 01/2010, Volume 115, Issue 2, pp. 379 - 387
Journal Article
Journal of Immunology, ISSN 0022-1767, 03/2015, Volume 194, Issue 5, pp. 2309 - 2318
Shiga toxin (Stx)-producing Escherichia coli (STEC) cause hemolytic uremic syndrome (HUS). This study investigated whether Stx2 induces hemolysis and whether... 
P2X RECEPTOR ACTIVATION | SYSTEM | POLYMORPHONUCLEAR LEUKOCYTES | STIMULATION | HUMAN ERYTHROCYTES | ESCHERICHIA-COLI | THROMBOTIC THROMBOCYTOPENIC PURPURA | IMMUNOLOGY | MICROPARTICLES | IDENTIFICATION | CLINICAL-RELEVANCE | Hemolysis - drug effects | L-Lactate Dehydrogenase - secretion | Complement C9 - chemistry | Shiga Toxin - chemistry | Humans | Middle Aged | Hemolytic-Uremic Syndrome - blood | Shiga Toxin - toxicity | Child, Preschool | Escherichia coli Infections - blood | Infant | Male | Complement Membrane Attack Complex - chemistry | Erythrocytes - chemistry | Hemolytic-Uremic Syndrome - pathology | Coated Vesicles - chemistry | Escherichia coli O157 - pathogenicity | Coated Vesicles - immunology | Complement C3 - chemistry | Hemolytic-Uremic Syndrome - microbiology | Antibodies, Monoclonal, Humanized - pharmacology | Receptors, Purinergic P2 - genetics | Edetic Acid - pharmacology | Erythrocytes - pathology | Purinergic P2 Receptor Antagonists - pharmacology | Adult | Female | Child | Receptors, Purinergic P2 - immunology | Complement Activation - drug effects | Suramin - pharmacology | Erythrocytes - immunology | Gene Expression | Escherichia coli O157 - metabolism | Escherichia coli Infections - microbiology | Shiga Toxin - immunology | Hemolytic-Uremic Syndrome - immunology | Erythrocytes - drug effects | Coated Vesicles - drug effects | Escherichia coli Infections - pathology | Escherichia coli Infections - immunology | Aged | Trihexosylceramides - immunology | Escherichia coli O157 - immunology | Anestesi och intensivvård | Anesthesiology and Intensive Care
Journal Article
Journal Article
Journal Article